| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_817a55451867f3cf22f82b9299e6c652
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9564450ae7d8b382ca2ea2023a752a74
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_85f4ac6d0f110b5d38280e1b87e1e603
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1b49b135f099e96a0e4cab2427a48ae8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d0550577d1056dfafb1ef28567b45416
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_45336e899635bce7be63df1bad908ee4 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2217-05
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2217-075
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-473
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47 |
| filingDate |
2001-10-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c46d0f15e5b1db3d091bed3a1e507880
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9f319d09acde84af8d054f81a8ce9554
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9f632bc42657905faede8d11031468c0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_27d2f00bceac7e5e63d1631a89d57390
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_925051678edd3895081b89c56573282c |
| publicationDate |
2003-04-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-0239923-A3 |
| titleOfInvention |
Inhibition of alpha-2 hs glycoprotein (ahsg/fetuin) in obesity and insulin control of glucose homeostasis |
| abstract |
The present iinvention is directed to new functions of the plasma glycoprotein alpha2-Heremans Schmid Glycoprotein, fetuin, leading to novel approaches to the treatment of obesity and to regulation of insulin control of glucose homeostasis. |
| priorityDate |
2000-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |